Cargando…
Expanding access to SARS-CoV-2 IgG and IgM serologic testing using fingerstick whole blood, plasma, and rapid lateral flow assays
Serologic testing for SARS-CoV-2 antibodies can be used to confirm diagnosis, estimate seroprevalence, screen convalescent plasma donors, and assess vaccine efficacy. Dried blood spot (DBS) samples have been used for serology testing of various diseases in resource-limited settings. We examined the...
Autores principales: | Anderson, Mark, Holzmayer, Vera, Vallari, Ana, Taylor, Russell, Moy, James, Cloherty, Gavin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111886/ https://www.ncbi.nlm.nih.gov/pubmed/34144453 http://dx.doi.org/10.1016/j.jcv.2021.104855 |
Ejemplares similares
-
A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay
por: Batra, Rahul, et al.
Publicado: (2020) -
Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis
por: Rahimi-Esboei, Bahman, et al.
Publicado: (2018) -
Performance Characteristics of the Vidas SARS-CoV-2 IgM and IgG Serological Assays
por: Renard, Nathalie, et al.
Publicado: (2021) -
Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research
por: Low, Swee Ling, et al.
Publicado: (2021) -
Evaluation of an Aspergillus IgG/IgM lateral flow assay for serodiagnosis of fungal asthma in Uganda
por: Kwizera, Richard, et al.
Publicado: (2021)